Grants per year
Personal profile
About
Dr. Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco currently serves as Chief Medical Officer, Providence Genomics, and as Member and Director of Translational Molecular Pathology and Molecular Genomics at the Earle A. Chiles Research Institute in Portland, Oregon, a division of Providence Cancer Institute. He oversees Providence Molecular Genomics Laboratory, one of the largest clinical genomics labs in the Pacific Northwest, which provides state-of-the-art genomic sequencing to cancer patients across the seven state PSJH system.
Prior to joining Providence, Dr. Bifulco served on the Pathology faculty at Yale University and completed fellowships in Oncologic Surgical Pathology and Molecular Genetic Pathology at Memorial Sloan Kettering Cancer Center. His current translational research is focused on supporting the characterization of the tumor immune microenvironment through immunohistochemical and image analysis techniques, and on the integration of genomics with immunotherapies. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC), and is Co-Chair of the SITC Pathology Task Force convened to establish multiplexed immunohistochemistry/ immunofluorescence (mIHC/IF) standards.
Education/Academic qualification
Memorial Sloan Kettering Cancer Center
State University of Milan, Italy
Yale University
Yale-New Haven Hospital
External positions
Director, Providence Portland Medical Center
Jan 1 2011 → Jan 1 2019
Director, Providence Portland Medical Center
Jan 1 2011 → Jan 1 2019
NCCCP Biospecimens, Co-Lead, Providence Portland Medical Center
Jan 1 2010 → Jan 1 2012
NCCCP Biospecimens, Co-Lead, Providence Portland Medical Center
Jan 1 2010 → Jan 1 2012
Attending, Providence Portland Medical Center
Jan 1 2008 → …
Attending, Providence Portland Medical Center
Jan 1 2008 → …
Director, Yale University
Jan 1 2006 → Jan 1 2008
Assistant Professor, University of Florida
Jan 1 2003
Assistant Professor, University of Florida
Jan 1 2003
Assistant Professor, Yale University
Jan 1 2003 → Jan 1 2007
Assistant Professor, Yale University
Jan 1 2003 → Jan 1 2007
Director, National Cancer Institute, Milan, Italy
Jan 1 2001 → Jan 1 2002
Director, National Cancer Institute, Milan, Italy
Jan 1 2001 → Jan 1 2002
Attending, National Cancer Institute, Milan, Italy
Jan 1 2000 → Jan 1 2002
Attending, National Cancer Institute, Milan, Italy
Jan 1 2000 → Jan 1 2002
Fingerprint
Dive into the research topics where Carlo Bifulco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 10 Finished
-
Applying machine learning techniques on routinely collected breast cancer data to improve patient outcomes
Bifulco, C. (PI)
01/1/20 → 01/1/21
Project: Research
-
Multispectral IHC to delineate the tumor environment in AML and monitor fluctuations with flotetuzumab
Bifulco, C. (CoI)
01/1/18 → 01/1/23
Project: Research
-
Understand the composition of immune cells in a tumor biopsy
Bifulco, C. (CoI)
01/1/18 → 01/1/22
Project: Research
-
-
Clinical validation of a multi-modal Ataraxis AI platform for recurrence prediction in early-stage breast cancer across multiple patient cohorts
Witowski, J., Choucair, K., Elayoubi, J., Chiru, E. D., Chan, N., Kang, Y. J., Howard, F. M., Ostrovnaya, I., Schnabel, F. R., Abdulsattar, W., Zong, Y., Daoud, L., Vetter, M., Pan, J. W., Laurinavičius, A., Piening, B., Bifulco, C. B., Brufsky, A., Esteva, F. J. & Pusztai, L., 2025, In: Journal of Clinical Oncology. 43, 16, 549.Research output: Contribution to journal › Article › peer-review
-
Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system
Wagner, J. T., Welle, J. T., Lucas Beckett, I. A., Emery, K. R., Cosgrove, B. A., Olszewski, K., Wagner, N., Bower, T. C., Yuan, L. C., Shull, E. M., Jade, K., Clemens, J., Magis, A. T., Campbell, M. B., Gordon, O. K., Bifulco, C. B. & Piening, B. D., 2025, In: Frontiers in Molecular Biosciences. 12, 1669085.Research output: Contribution to journal › Article › peer-review
Open Access -
Geno4ME Study: implementation of whole genome sequencing for population screening in a large healthcare system
Lucas Beckett, I. A., Emery, K. R., Wagner, J. T., Jade, K., Cosgrove, B. A., Welle, J., Rinaldi, J. B., Dickey, L., Jones, K., Wagner, N., Shull, E. M., Clemens, J., Trachana, K., Anderson, L., Kudla, A., Smith, B., Verespej, H., Yuan, L. C., Denne, E. & Ramos, E. & 14 others, , Dec 2025, In: npj Genomic Medicine. 10, 1, 50.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1
Tran, T. T., Sánchez-Zuno, G. A., Osmani, L., Caulfield, J., Valdez, C. N., Piecychna, M., Leng, L., Armstrong, M. E., Donnelly, S. C., Bifulco, C. B., Clister, T., Kulkarni, R. P., Zhang, L., Sznol, M., Jilaveanu, L., Kluger, H. M., Kang, I. & Bucala, R., Oct 22 2025, In: JCI Insight. 10, 20Research output: Contribution to journal › Article › peer-review
Open Access -
SITC perspective: Leveraging patient enrichment biomarkers to accelerate early phase IO drug development
Emens, L. A., Moussion, C., Hwu, P., Gulley, J. L., Ohashi, P. S., Bifulco, C. B. & Feltquate, D., Jun 22 2025, In: Journal for ImmunoTherapy of Cancer. 13, 6, e010739.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations